Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

16.39 +0.10 (+0.61%)
Streaming Delayed Price Updated: 10:31 AM EDT, Jun 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theravance Biopharma, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Why Theravance Biopharma Stock Is Trading Lower After Hours ↗
Theravance Biopharma Inc (NASDAQ: TBPH) shares are trading lower in Monday's after-hours session after the company announced the results from Study 0170 showed the... 
Via Benzinga
News headline image
World Markets News For Friday ↗
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%. 
Via Talk Markets
News headline image
Red Ink ↗
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph 
Via Talk Markets
News headline image
Expert Ratings For Theravance Biopharma ↗
Within the last quarter, Theravance Biopharma (NASDAQ:TBPH) has observed t... 
Via Benzinga
News headline image
Recap: Theravance Biopharma Q4 Earnings ↗
Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc... 
Via Benzinga
News headline image
Give peace a chance ↗
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
Via Talk Markets
News headline image
Nuclear Winter ↗
Mexico is raising interest rates to 6%, from 5.5%. 
Via Talk Markets
News headline image
Earnings Scheduled For February 23, 2022 ↗
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)... 
Via Benzinga
News headline image
The Last Day In January ↗
The market is suspicious of the moves up to right matters. 
Via Talk Markets
News headline image
More Serious Matters ↗
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Immuron (NASDAQ:IMRN) shares rose 36.6% to $3.58 during Wednesday's regular session. Trading volume for this security as of 12:32 EST is 35.0 million, which is... 
Via Benzinga
News headline image
28 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing... 
Via Benzinga
News headline image
50 Biggest Movers From Yesterday ↗
Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for... 
Via Benzinga
News headline image
48 Biggest Movers From Yesterday ↗
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT... 
Via Benzinga
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-... 
Via Benzinga
News headline image
To sell or not to sell? ↗
Pfizer says its covid pill is 90% effective. PFE got higher target prices from Berenburg and Mizuho 
Via Talk Markets
News headline image
Wednesday Global Investing Report ↗
Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international... 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's... 
Via Benzinga
News headline image
Thursday Markets Overview ↗
Today we are seeing an across-the-board rise in stock prices on hopes for lower inflation and Omicron jabbing. 
Via Talk Markets
News headline image
Happy December ↗
Inflation levels this year will almost certainly lower growth in 2022 because of inflation this year in everything from house prices....to stock prices. 
Via Talk Markets
News headline image
Theravance Biopharma Pulls Plug On Izencitinib Crohn's Disease Trial ↗
Theravance Biopharma Inc (NASDAQ: TBPH) has voluntarily discontinued its Phase 2 study of izencitinib (gut-selective oral pan-JAK inhibitor) in Crohn’s... 
Via Benzinga
News headline image
Veteran's Day ↗
Stock markets took a tumble today across the board, but not as far down as at the opening. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021 ↗
Upgrades For IGM Biosciences Inc (NASDAQ: 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Jobs Report ↗
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the S&P 500 and Nasdaq surged to record highs in the previous session. Investors are awaiting... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million... 
Via Benzinga
News headline image
Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript ↗
TBPH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.